Clinical Trial
ICRF-159 versus polychemotherapy in non-small cell lung cancer
- PMID: 64297
Item in Clipboard
Clinical Trial
ICRF-159 versus polychemotherapy in non-small cell lung cancer
Cancer Treat Rep.
1976 Jul.
No abstract available
Similar articles
-
VP-16-213 versus polychemotherapy in patients with advanced small cell lung cancer.Cancer Treat Rep. 1976 Jul;60(7):949-51. Cancer Treat Rep. 1976. PMID: 64298 Clinical Trial. No abstract available.
-
Phase II trial of ICRF-187 in non-small cell lung cancer.Cancer Treat Rep. 1983 Mar;67(3):311-3. Cancer Treat Rep. 1983. PMID: 6403240 No abstract available.
-
Phase II studies of polychemotherapy regimens in small cell lung cancer.Cancer Treat Rep. 1977 Jan-Feb;61(1):93-5. Cancer Treat Rep. 1977. PMID: 861966 Clinical Trial. No abstract available.
-
The role of chemotherapy in the treatment of lung cancer.Semin Oncol. 1974 Sep;1(3):259-72. Semin Oncol. 1974. PMID: 4143488 Review. No abstract available.
-
ICRF-187 in clinical oncology.Cancer Clin Trials. 1981;4(2):143-6. Cancer Clin Trials. 1981. PMID: 6788388 Review.
Cited by
-
Single-agent chemotherapy for advanced adenocarcinoma of the lung. A review.Cancer Chemother Pharmacol. 1988;21(2):89-102. doi: 10.1007/BF00257354. Cancer Chemother Pharmacol. 1988. PMID: 3280154 Review.
-
Combination chemotherapy for advanced adenocarcinoma of the lung. A review.Cancer Chemother Pharmacol. 1988;21(2):103-16. doi: 10.1007/BF00257355. Cancer Chemother Pharmacol. 1988. PMID: 3280152 Review.
-
Cisplatin, vinblastine, and bleomycin in inoperable non-small cell lung cancer.Thorax. 1985 May;40(5):346-50. doi: 10.1136/thx.40.5.346. Thorax. 1985. PMID: 2410994 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources